| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |